ANEB icon

Anebulo Pharmaceuticals

12 hedge funds and large institutions have $16.5M invested in Anebulo Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
2L
1
22NW LP
Washington
$11.9M
LA
2
LVW Advisors
New York
$1.58M -$2.35K -1,000 -0.1%
NCM
3
Nantahala Capital Management
Connecticut
$1.2M
MP
4
Mangrove Partners
Connecticut
$938K
PP
5
Praetorian PR
Puerto Rico
$423K +$423K +180,005 New
IC
6
Ikarian Capital
Texas
$341K
BFM
7
Boothbay Fund Management
New York
$40.7K
Vanguard Group
8
Vanguard Group
Pennsylvania
$37.7K +$37.7K +16,032 New
BlackRock
9
BlackRock
New York
$17K -$658 -280 -4%
TRCT
10
Tower Research Capital (TRC)
New York
$14.3K +$2.34K +994 +19%
Wells Fargo
11
Wells Fargo
California
$134 +$5 +2 +4%